Carbapenem-Resistant Bacteria Recovered from Faeces of Dairy Cattle in the High Plains Region of the USA
暂无分享,去创建一个
Hattie E. Webb | Guy H. Loneragan | H. D. den Bakker | K. Nightingale | M. Bugarel | S. Granier | H. M. Scott | G. Loneragan | Marie Bugarel | Henk C. den Bakker | Kendra K. Nightingale | Sophie A. Granier | H. Morgan Scott | H. E. Webb | H. Webb | H. C. D. Bakker | Sophie | A. Granier
[1] Efsa Publication. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on Carbapenem resistance in food animal ecosystems , 2014 .
[2] Thierry Naas,et al. Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.
[3] P. Nordmann,et al. In Vivo Acquisition of High-Level Resistance to Imipenem in Escherichia coli , 2004, Journal of Clinical Microbiology.
[4] P. Nordmann,et al. Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[5] P. Nordmann,et al. Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.
[6] H. Bayley,et al. Altered Antibiotic Transport in OmpC Mutants Isolated from a Series of Clinical Strains of Multi-Drug Resistant E. coli , 2011, PloS one.
[7] I. Booth,et al. Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long‐term antibiotic therapy , 2001, Molecular microbiology.
[8] E. Denamur,et al. Escherichia , 2020, Definitions.
[9] B. Guerra,et al. Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. , 2013, The Journal of antimicrobial chemotherapy.
[10] S. Rasmussen,et al. Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.
[11] P. Nordmann,et al. The carbapenemase threat in the animal world: the wrong culprit. , 2014, The Journal of antimicrobial chemotherapy.
[12] K. Bush,et al. Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.
[13] L. Simmons,et al. Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease , 2014, Genome Medicine.
[14] A. Zavascki,et al. Performance of Quantification of Modified Hodge Test: An Evaluation with Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Isolates , 2014, BioMed research international.
[15] Michael Bell,et al. Vital Signs: Carbapenem-Resistant Enterobacteriaceae , 2013, MMWR. Morbidity and mortality weekly report.
[16] B. Norby,et al. Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. , 2007, American journal of veterinary research.
[17] M. Vaneechoutte,et al. OXA-23-producing Acinetobacter species from horses: a public health hazard? , 2012, The Journal of antimicrobial chemotherapy.
[18] J. Rolain,et al. ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes , 2013, Antimicrobial Agents and Chemotherapy.
[19] A. Carattoli. Animal reservoirs for extended spectrum beta-lactamase producers. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[20] J. Stetefeld,et al. Modeling of Molecular Interaction between Apoptin, BCR-Abl and CrkL - An Alternative Approach to Conventional Rational Drug Design , 2012, PloS one.
[21] I. Henriques,et al. Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms. , 2015, Microbial drug resistance.
[22] P. Nordmann,et al. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[23] S. Pournaras,et al. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. , 2010, The Journal of antimicrobial chemotherapy.
[24] D. Livermore. The zeitgeist of resistance. , 2007, The Journal of antimicrobial chemotherapy.
[25] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[26] Justin Zobel,et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs , 2014, bioRxiv.
[27] R. Rosselló-Móra,et al. Shifting the genomic gold standard for the prokaryotic species definition , 2009, Proceedings of the National Academy of Sciences.
[28] D. Livermore,et al. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Matthew N. Benedict,et al. ITEP: An integrated toolkit for exploration of microbial pan-genomes , 2014, BMC Genomics.
[30] Daniel Falush,et al. Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.
[31] P. Nordmann,et al. Detection of Carbapenemase Producers in Enterobacteriaceae by Use of a Novel Screening Medium , 2012, Journal of Clinical Microbiology.
[32] G. Rossolini,et al. Distribution of cphA or related carbapenemase-encoding genes and production of carbapenemase activity in members of the genus Aeromonas , 1995, Antimicrobial agents and chemotherapy.
[33] P. Nordmann,et al. Evaluation of the RAPIDEC® CARBA NP, the Rapid CARB Screen® and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae. , 2015, The Journal of antimicrobial chemotherapy.
[34] S. Ramos,et al. 5-Lipoxygenase Deficiency Impairs Innate and Adaptive Immune Responses during Fungal Infection , 2012, PloS one.
[35] Samir N. Patel,et al. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .
[36] V. Miriagou,et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[37] Siguo Liu,et al. Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. , 2013, The Journal of antimicrobial chemotherapy.
[38] Mary Jane Ferraro,et al. Performance standards for antimicrobial susceptibility testing : twelfth informational supplement , 2002 .
[39] S. Amyes,et al. OXA β-Lactamases , 2014, Clinical Microbiology Reviews.
[40] A. Carattoli. Animal reservoirs for extended spectrum β-lactamase producers , 2008 .
[41] Efsa Publication,et al. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on Carbapenem resistance in food animal ecosystems , 2014 .
[42] F. Baquero,et al. In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia , 2001, Antimicrobial Agents and Chemotherapy.
[43] Andrés Moya,et al. Virulence factor rtx in Legionella pneumophila, evidence suggesting it is a modular multifunctional protein , 2008, BMC Genomics.
[44] Y. Carmeli,et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] L. Dijkshoorn,et al. The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.
[46] M. Augenbraun,et al. Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae , 2009, Infection Control & Hospital Epidemiology.
[47] T. Mahjoub,et al. CTLA-4 gene polymorphisms and risk of idiopathic recurrent pregnancy loss in a Tunisian population , 2014, BMC Genomics.
[48] Qijing Zhang,et al. Identification of New Delhi Metallo-β-lactamase 1 in Acinetobacter lwoffii of Food Animal Origin , 2012, PloS one.
[49] M. Facciotti,et al. An Integrated Pipeline for de Novo Assembly of Microbial Genomes , 2012, PloS one.
[50] B. Berçot,et al. Carbapenemase-producing Acinetobacter spp. in Cattle, France , 2012, Emerging infectious diseases.
[51] F. Rodríguez-Valera,et al. Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.
[52] P. Nordmann,et al. Rapid Detection of Carbapenemase-producing Enterobacteriaceae , 2012, Emerging infectious diseases.
[53] K. Bush,et al. The ABCD’s of β-lactamase nomenclature , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.